Published June 3, 2005 | Version v1
Journal article

TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage

  • 1. Department of Obstetric and Genecology, Juntendo University School of Medicine, Tokyo 113-8421 (Japan)
  • 2. Department of Immunology, Juntendo University School of Medicine, Tokyo 113-8421 (Japan)

Description

TWEAK induces diverse cellular responses, including pro-inflammatory chemokine production, migration, proliferation, and cell death through the TWEAK receptor, Fn14. In the present study, we examined the effect of TWEAK or Fn14 expression in tumor cells on tumor outgrowth in vivo. Administration of neutralizing anti-TWEAK mAb significantly reduced the frequency of tumor rejection and shortened the survival of mice intraperitoneally inoculated with TWEAK-sensitive Fn14-expressing tumor cells. Moreover, anti-TWEAK mAb treatment promoted the subcutaneous growth of TWEAK-sensitive Fn14-expressing tumor cells, and this promotion was abolished by the inhibition of macrophage infiltration but not NK cell depletion. In contrast, administration of anti-TWEAK mAb had no apparent effect on the growth of TWEAK-resistant tumor cells, even if tumor cells expressed Fn14. On the other hand, TWEAK expression in tumor cells had no significant effect on subcutaneous tumor growth. These results indicate that TWEAK mediates anti-tumor effect of macrophages in vivo

Additional details

Identifiers

DOI
10.1016/j.bbrc.2005.03.176;
PII
S0006-291X(05)00669-8;

Publishing Information

Journal Title
Biochemical and Biophysical Research Communications
Journal Volume
331
Journal Issue
2
Journal Page Range
p. 384-390
ISSN
0006-291X
CODEN
BBRCA9

Optional Information

Copyright
Copyright (c) 2005 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.